Our website uses cookies to improve your on-site experience. By using the website, cookies are being used as described in our Policy Document
Warning: To log in you will need to enable cookies and reload the page (Policy Document)
My ePortfolio Register   
 

Abstract | Full HTML Article | PDF ecancer 13 891 / https://doi.org/10.3332/ecancer.2019.891

Research

Proteomics characterisation of central nervous system metastasis biomarkers in triple negative breast cancer

Background: Breast cancer (BC) is the most frequent tumour in women. Triple negative tumours (TNBC)–which are associated with minor survival rates—lack markers predictive of response to anticancer drugs. Triple negative tumours frequently metastasise to the central nervous system (CNS).

Objective: The main objective of this study was to study differences in tumour protein expression between patients with CNS metastases and those without this kind of spread, and propose new biomarkers.

Methods: A retrospective study was performed. Targeted proteomics and statistical analyses were used to identify possible biomarkers.

Results: Proteins were quantified by a targeted proteomics approach and protein expression data were successfully obtained from 51 triple negative formalin-fixed paraffin-embedded samples. ISG15, THBS1 and AP1M1 were identified as possible biomarkers related with CNS metastasis development.

Conclusions: Three possible biomarkers associated with CNS metastases in TNBC tumours were identified: ISG15, THBS1 and AP1M1. They may become markers predicting the appearance of CNS infiltration in triple negative BC.

Keywords: breast cancer, triple negative, proteomics, central nervous system metastases, biomarkers, personalised medicine

Loading Article Metrics ... Please wait

Related articles

Review: Is there any benefit to particles over photon radiotherapy?

Abstract | Full Article | PDF Published: 09 Dec 2019 / https://doi.org/10.3332/ecancer.2019.982

Conference Report: Cancer in pregnancy: an association to make one shiver—highlights from ‘Cancer in pregnancy: 15 years after’, 10–11 October 2019, Milan, Italy

Abstract | Full Article | PDF Published: 03 Dec 2019 / https://doi.org/10.3332/ecancer.2019.981

Review: Advances in pain management for older patients with cancer

Abstract | Full Article | PDF Published: 03 Dec 2019 / https://doi.org/10.3332/ecancer.2019.980

Case Report: Can we trust tumour markers in pregnancy after breast cancer? A case of elevated CA 15-3 in the third trimester of pregnancy normalising after delivery

Abstract | Full Article | PDF Published: 26 Nov 2019 / https://doi.org/10.3332/ecancer.2019.979

Research: Awareness of human papilloma virus and cervical cancer prevention among Cypriot female healthcare workers

Abstract | Full Article | PDF Published: 20 Nov 2019 / https://doi.org/10.3332/ecancer.2019.978



Founding partners

European Cancer Organisation European Institute of Oncology

Founding Charities

Foundazione Umberto Veronesi Fondazione IEO Swiss Bridge

Published by

ecancer Global Foundation